Exscientia pulls in $225m Series D

Exscientia, a clinical stage pharmatech company, has raised $225 million in Series D funding.

Exscientia, a clinical stage pharmatech company, has raised $225 million in Series D funding. SoftBank Vision Fund 2i led the round.

Source: Press Release